Dengue in an area of the Colombian Caribbean
Article Sidebar
Main Article Content
Background: In Colombia, dengue is an endemic disease and the four serotypes have been reported. The objective of present study was to describe the frequency and severity of dengue in an area of the Colombian Caribbean (department of Cordoba)
Methodology: A retrospective study was conducted. Two data sources were analysed: The database from the Direction of Health in Córdoba, and clinical registers of patients diagnosed with haemorrhagic fevers and fevers of unknown origin in reference hospitals.
Results: The mean incidence of dengue between 2003-2010 was 36.5 cases per 105 inhabitants (CI95%: 34.3 – 37.5) and adjusted for sub-reporting, could be between 178.5 and 521.6. The mean incidence of severe dengue was 4.7 cases per 105 inhabitants (CI95%: 4.3 – 5.0). Mean mortality rate due to dengue was 0.3 cases per 105 inhabitants. The fatality rate was below 1%. The mean total leukocyte count in patients with dengue was 6181 mm3 (CI95%: 5973 – 6389) and with Severe Dengue it was 4729 mm3 (CI95%: 4220 – 5238). The average platelet count in patients with Dengue was 118,793/mm3 (CI95%: 107,255 – 130,331) and in patients with Severe Dengue 77,655 (CI95%: 59,640 - 95,670). Both differences were statistically significant (p< 0.05). The frequency of laboratories test per patient in patients with Dengue and Severe Dengue were different.
Conclusion: The department of Cordoba is a highly endemic zone of Dengue and Severe Dengue in the Colombian Caribbean.
- Colombia
- diagnosis
- dengue
- severe dengue
- surveillance
Potts J, Gibbons R, Rothman A, Srikiatkhachorn A, Thomas S, Supradish P, et al. Prediction of dengue disease severity among pediatric Thai patients using early clinical laboratory indicators. PLoS Negl Trop Dis. 2010; 4(8): e769. DOI: https://doi.org/10.1371/journal.pntd.0000769
WHO . Dengue and severe dengue. WHO media centre; 2014. Accessed: 2011 Jan 15. Available from: http://www.who.int/mediacentre/factsheets/fs117/en/.
WHO . Dengue guidelines for diagnosis, treatment, prevention and control. Francia: World Health Organization, TDR; 2009. Accessed; 2011 Jan 15. Available from: http://whqlibdoc.who.int/publications/2009/9789241547871_eng.pdf.
Shepard DS, Coudeville L, Halasa YA, Zambrano B, Dayan GH. Economic impact of dengue illness in the Americas. Am J Trop Med Hyg. 2011; 84(2): 200–7. DOI: https://doi.org/10.4269/ajtmh.2011.10-0503
Murillo-Llanes J, Soto-Valenzuela H, Flores-Flores P, Peraza-Garay F. Caracterización clínica y epidemiológica del dengue. Rev Med Inst Mex Seguro Soc. 2007; 45(5): 485–91.
Instituto Nacional de Salud,Dirección de Vigilancia y Análisis del Riesgo en Salud Pública Enfermedades Transmitidas por vectores. Boletín Epidemiológico Semanal. 2014; 53:17–22.
Camacho T , de la Hoz F, Cárdenas T, Sánchez C, de Calderón L, Pérez L, et al. Incomplete surveillance of a dengue-2 epidemic in Ibague, Colombia, 1995-1997. Biomedica. 2004; 24(2): 174–82. DOI: https://doi.org/10.7705/biomedica.v24i2.1263
DANE. Demografía y Población. Accessed: 20 August 2010; Available from: http://www.dane.gov.co/index.php/poblacion-y-demografia/proyecciones-de-poblacion.
Wilder SA, Gubler D. Geographic expansion of dengue: the impact of international travel. Med Clin North Am. 2008; 92(6): 1377–90. DOI: https://doi.org/10.1016/j.mcna.2008.07.002
Jansen C, Beebe N. The dengue vector Aedes aegypti: what comes next. Microbes Infect. 2010; 12(4): 272–9. DOI: https://doi.org/10.1016/j.micinf.2009.12.011
Añez G, Balza R, Valero N, Larreal Y. Economic impact of dengue and dengue hemorrhagic fever in the State of Zulia, Venezuela, 1997-2003. Rev Panam Salud Publica. 2006; 19(5): 314–20. DOI: https://doi.org/10.1590/S1020-49892006000500004
Ocazionez R, Gómez S, Cortés F. Serotipo, patrón de infección y dengue hemorrágico en área endémica colombiana. Rev Salud Pública. 2007; 9(2): 262–74. DOI: https://doi.org/10.1590/S0124-00642007000200010
Escobar MJ, Gómez DH. Determinantes de la transmisión de dengue en Veracruz: un abordaje ecológico para su control. Salud Pública Mex. 2003; 45(1): 43–53. DOI: https://doi.org/10.1590/S0036-36342003000100006
Penna G, Pinto L, Soranz D, Glatt R. High Incidence of diseases endemic to the Amazon region of Brazil, 2001-2006. Emerg Infect Dis. 2009; 15(4): 626–39. DOI: https://doi.org/10.3201/eid1504.081329
Torres E. Dengue. Estudos Avançados. 2008; 22(64): 33–52. DOI: https://doi.org/10.1590/S0103-40142008000300004
Guha SD, Schimmer B. Dengue fever: new paradigms for a changing epidemiology. Emerg Themes Epidemiol. 2005; 2(1): 1–10. DOI: https://doi.org/10.1186/1742-7622-2-1
Arbo A, Bogado N. Nuevas Guías de Tratamiento del Dengue. Pediatr (Asunción). 2011; 38(1): 7–8.
Salgado D, Vega M, Garzón M, Panqueba C, Rodriguez J. Mortalidad por dengue hemorrágico en niños en Colombia: más allá del choque. Infectio. 2008; 12(1): 247–53.
Villegas-Trejo A, Che-Mendoza A, González-Fernández M, Guillermo-May G, González-Bejarano H, Dzul-Manzanilla F, et al. Control enfocado deAedes aegypti en localidades de alto riesgo de transmisión de dengue en Morelos, México. Salud Pública Mex. 2011; 53(2): 141–51. DOI: https://doi.org/10.1590/S0036-36342011000200007
Salgado D, Rodríguez J, Garzón M, Cifuentes G, Ibarra M, Vega M, et al. Caracterización clínica y epidemiológica de dengue hemorrágico en Neiva, Colombia, 2004. Rev Salud Pública (Bogota). 2007; 9(1): 53–63. DOI: https://doi.org/10.1590/S0124-00642007000100006
Armien B, Suaya J, Quiroz E, Sah B, Bayard V, Marchena L, et al. Clinical characteristics and national economic cost of the 2005 dengue epidemic in Panama. Am J Trop Med Hyg. 2008; 79(3): 364–71. DOI: https://doi.org/10.4269/ajtmh.2008.79.364
Mamani E, Figueroa D, García M, Garaycochea MdelC, Pozo E. Infecciones concurrentes por dos serotipos del Virus dengue durante un brote en el noroeste de Perú, 2008. Rev Perú Med Exp Salud Publica. 2010; 27(1): 16–21. DOI: https://doi.org/10.1590/S1726-46342010000100004
Rey JR, Lounibos LP, Padmanabha H, Mosquera M. Resurgencia del dengue en América: pautas, procesos y prospectos. Interciencia. 2010; 35(11): 800–6.
Sánchez CR, Torres ZR, Segovia SF, Reyes VF, Alvarado MM, Fernández SI. Localización de criaderos no residenciales de Aedes aegypti y su asociación con casos de dengue en la zona Metropolitana de Monterrey, Nuevo León, Mexico. Rev Salud Pública Nutrición. 2010; 11(1): 1–6.
Ospina MC. Vigilancia epidemiológica del dengue en Antioquia. IATREIA. 2004; 17(3): 283–4.
Rivera A, Rodríguez A. Actualización en aspectos epidemiológicos y clínicos del dengue. Rev Cub Salud Pública. 2010; 36(1): 149–64. DOI: https://doi.org/10.1590/S0864-34662010000100015
Romero-Vivas C, Arango-Padilla P, Falconar A. Pupal-productivity surveys to identify the key container habitats of Aedes aegypti (L.)) in Barranquilla, the principal seaport of Colombia. Ann Trop Med Parasitol. 2006; 100(1): 87–95. DOI: https://doi.org/10.1179/136485906X105543
Ramírez ZM, Velasco MH, Ramos C, Peñuelas J, Maradiaga CM, Murillo LJ, et al. Caracterización clínica y epidemiológica de los casos de dengue: experiencia del Hospital General de Culiacán, Sinaloa, México. Rev Panam Salud Publica. 2009; 25(1): 16–23. DOI: https://doi.org/10.1590/S1020-49892009000100003
Acosta CB, Gómez IC. Biología y métodos diagnósticos del dengue. Rev Biomed. 2005; 16(2): 113–37. DOI: https://doi.org/10.32776/revbiomed.v16i2.408
Castrillón M, Iturrieta N, Cativelli S, Padilla F. Hallazgos ultrasonográficos en pacientes con Dengue. Revisión de la literatura. RAR. 2010; 74(1): 70–6.
Ramírez J, Aguirre A, Velandia R, Rosero H, García R, Ospina J, et al. Fiebre por dengue: guías de manejo. Rev Med Risaralda. 2010; 16(1): 41–51.
Pizarro D. Dengue, Dengue hemorrágico. Acta Pediátr Costarric. 2009; 21(1): 8–17.
Villar CL. El dengue: la epidemia se extiende y urgen intervenciones efectivas y herramientas clínicas para su atención. Infectio. 2008; 12(1): 9–10.
Kourí G, Pelegrino J, Munster B, Guzmán M. Sociedad, economia, inequidades y dengue. Rev Cubana Med Trop. 2007; 59(3): 177–85.
Gomez-Dantés H, Willoquet J. Dengue in the Americas: challenges for prevention and control. Cad Saude Publica. 2009; 25(1): 19–31. DOI: https://doi.org/10.1590/S0102-311X2009001300003
Downloads
Similar Articles
- Nicolas Iragorri, Carlos Gómez-Restrepo, Kali Barrett, Socrates Herrera, Isabel Hurtado, Yasin Khan, Stephen Mac, David Naimark, Petros Pechlivanoglou, Diego Rosselli, Dilian Francisca Toro, Pedro Villamizar, Raphael Ximenes, Helmer Zapata, Beate Sander, COVID-19: Adaptation of a model to predict healthcare resource needs in Valle del Cauca, Colombia , Colombia Medica: Vol. 51 No. 3 (2020)
- María Lilia Diaz Betancourth, Julio Cesar Klinger, Victoria Eugenia Niño, Profound CD4+ T lymphocytopenia in human immunodeficiency virus negative individuals, improved with anti-human herpes virus treatment , Colombia Medica: Vol. 43 No. 4 (2012): Numbers in cancer: 50-year of The Population-based Cancer Registry of Cali
- Elvia Karina Grillo Ardila, Luis Eduardo Bravo Ocaña, Rodrigo Guerrero, Julián Santaella-Tenorio, Mathematical models and the coronavirus, COVID-19 , Colombia Medica: Vol. 51 No. 2 (2020): Coronavirus disease 2019
You may also start an advanced similarity search for this article.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use